Hints and tips:
Related Special Reports
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...“Africa is a key market for Sputnik V,” said the Russian Direct Investment Fund, a Kremlin-run wealth fund overseeing Sputnik V’s foreign sales....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...If there is a sense from this earnings season that confidence in a V-shaped recovery for profits is misplaced, then the impact will probably be hardest on companies with weak balance sheets, and on those...
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
...Leon Kalvaria, New York-based chairman of Citigroup’s investment bank, said Citi’s return to the office would be “gradual”....
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
...More recently, Leon Cooperman of Omega Advisors took the same step....
...She worked as a janitorial supervisor at C&W client Lonza, a Swiss pharmaceuticals group, which has a production facility in Portsmouth, New Hampshire....
...George Soros, BlueCrest’s Michael Platt and Leon Cooperman of Omega Advisors are among the prominent industry figures who have done so since the crisis....
...Zydus Pharmacuticuals (USA), Inc....
...He places human embryonic and pluripotent stem cells — that have the potential to grow into nearly every cell of the body — in tiny ‘U’ or ‘V’ shaped dishes in the lab to grow them into different types of...
...Private equity titans like Leon Black and Steve Schwarzman became billionaires in part by slashing every extraneous cost at their portfolio companies....
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...the neuroscience business should not “shock investors but is likely to raise a debate over possible use of proceeds should any cash be generated and management of any earnings dilution [ie deleveraging v...
...Mr Cooperman has also said that the US Attorney in New Jersey’s investigation of him and his firm is on hold, “pending the Supreme Court’s decision in Salman v United States”....
...Bill Ackman, one of Wall Street’s flashiest showmen, made the largest single loss of his career putting a fifth of his fund into Valeant Pharmaceuticals....
...Leon Cooperman, chief executive of Omega Advisors, who is facing civil insider trading charges from the Securities and Exchange Commission, has told investors that prosecutors were waiting for the Salman...
...David Maris, a pharmaceuticals analyst at Wells Fargo, says he has “mixed feelings” about such tactics....
...Leon Cooperman tipped stocks including Citigroup and General Motors, while Jana Partners founder Barry Rosenstein widened his criticism of strategy at Qualcomm, where he has a $2bn stake....
...Aberdeen Asset Management and Canada Pension Plan have also voiced opposition to the deal, as has the local company Ilsung Pharmaceuticals, which holds 2 per cent....
...Leon Ferera, partner at Jones Day, who was formerly seconded to the panel, said: “Now that the panel has proposed these changes, parties to an offer will need to think hard about whether they want to give...
...Leon Kamhi, executive director at Hermes Executive Ownership Services, which advises investors including the BT Pension scheme, the UK’s largest corporate pension fund, on their investments, says: “Our stance...
International Edition